Blenrep Combo for Relapsed, Refractory Myeloma Improves Outcomes

Patients with relapsed or refractory multiple myeloma had lower progressive disease outcomes when receiving Blenrep with Velcade and dexamethasone, research found.

Related Keywords

Salamanca ,Castillay Leóp ,Spain ,Hesham Abdullah ,University Of Salamanca ,National Cancer Institute ,National Cancer ,Victoria Mateos ,News ,Myeloma ,Multiple Myeloma ,Blenrep ,Darzalex ,